FLT1 and gastric cancer: It is of note that there was no significant difference in VEGFR1 expression levels in the 18 cases with metastasis at the time of operation compared with the 12 cases with postoperative recurrence; however, 30 cases with recurrence/metastasis expressed a significantly higher level of VEGFR1 than the 60 gastric cancer cases without metastasis/recurrence (Figure 2).